Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Download PDF

Migraine and tension headache comorbidity with hypothyroidism in Egypt

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery volume 56, Article number: 78 (2020) Cite this article

Abstract

Background

Migraine, tension type headache (TTH), and hypothyroidism are clinical problems that affect patient daily activities and quality of life.

Objectives

The purpose of this study was to investigate the potential association between hypothyroidism in patients with migraine and TTH.

Patients and methods

Two hundred and twelve patients with migraine and TTH and one hundred control subjects underwent clinical evaluation, assessment of thyroid hormones, and thyroid ultrasound.

Results

Subclinical and overt hypothyroidism were significantly higher in patients with migraine and TTH (P = 0.001) than control subjects. Patients with migraine and TTH showed significantly more abnormal thyroid gland morphology than healthy control (P = 0.027). Hypothyroidism is significantly expressed in chronic TTH more than TTH with infrequent or frequent TTH (P = 0.009).

Conclusions

Patients having migraine and TTH more prone to develop hypothyroidism when compared with control group. Also patients with chronic TTH are susceptible to develop hypothyroidism (either subclinical or overt) when compared with patients having frequent or infrequent TTH.

Introduction

Migraine and tension type headache (TTH) disorders are among the top six most prevalent disorders and the third cause of disability worldwide in individuals under the age of 50 with a major impact on activities of daily living and quality of life [1, 2].

Tension-type headache (TTH) is defined as a mild to moderate band-like pressure headache associated with some somatic and emotional symptoms. The frequency and duration of TH varied from infrequent episodes of a headache to frequent, long-lasting, or even chronic [3].

Typical characteristics of migraine headache are unilateral location, pulsating quality, moderate or severe intensity, aggravation by routine physical activity, and association with nausea and/or photophobia and phonophobia [4].

Hypothyroidism prevalence in general population in Europe ranged between 0.2 and 5.3% and usually this represents thyroid hormone deficiency. It affects women more than men and is more common in older age (≥ 65 years) with clinical burden related to major organs including neurological symptoms [5].

Hypothyroidism represents one of non-neurological comorbidities of migraine. These comorbidities (refers to the greater than coincidental association of separate conditions) significantly influence the progression of headache and may interact with choosing the therapeutic strategies [6, 2].

Recent studies explained the comorbidity by involvement of thyroid hormone in pain mechanisms with thyrotropin stimulating hormone receptors being expressed in the cortical neurons and cerebral vasculature [7].

Many studies defined a bidirectional relationship between migraine, TH, and hypothyroidism including underlying pathophysiological aspects. However up till now, there is contradictory data about these relationship [8]. There is uncertainty in pathogenesis of development of migraine, tension TH in hypothyroidism; some proposed the alterations in the immune system and autonomic nervous system with shared genetic or environmental factors [9].

The purpose of this study was to investigate the potential association between hypothyroidism in patients with migraine and tension headache.

Subjects and methods

Subjects

In a cross-sectional study, we investigated two hundred and twelve patients with migraine and tension type headache and one hundred, age- and sex-matched healthy control subjects. Patients were recruited from neurology outpatient clinics of Helwan University Hospitals, Egypt, from May 2019 to December 2019.

Inclusion criteria in this study were patients of both sex with age ranged from 18 to 55 years.

All patients underwent full history taking stressing on headache characteristics, severity, frequency, and medications used. Frequent headache attacks are defined by headache more than 10 attacks per month (at least 10 episodes of headache occurring on 1-14 days/month on average for > 3 months (≥ 12 and < 180 days/year)) [4]. Infrequent headache is defined as at least 10 episodes of headache occurring on < 1 day/month on average (< 12 days/year) [4, 10]. Patients with migraine headache were diagnosed according to the International Classification of Headache Disorders (ICHD)-III beta criteria [8]. It includes recurrent headache manifesting in attacks lasting 4–72 h. Typical characteristics of the headache are unilateral location, pulsating quality, moderate or severe intensity, aggravation by routine physical activity, and association with nausea and/or photophobia and phonophobia. Chronic migraine is defined as headache occurring on 15 or more days per month for more than 3 months, which, on at least 8 days per month, has the features of migraine headache [4].

Patients with tension type headache was diagnosed according to the International Classification of Headache Disorders (ICHD)-III beta criteria [4]. All patients must have all of the following four headache characteristics: bilateral, mild-to-moderate intensity, non-pulsating headache not aggravated by routine physical activity, and their headaches must not be associated with any of nausea, vomiting, photophobia, or phonophobia. Chronic tension headache means that type of tension headache lasts hours and may be continuous and if headaches occur 15 or more days a month for at least 3 months [4, 11]. Normal neurological examination. Completely normal laboratory tests (complete blood count, creatinine, liver function tests)

Exclusion criteria included patients that were beyond the range of 18-55 years, showed abnormal neurological examination, and or had chronic illness known to affect thyroid dysfunction (chronic kidney disease, psychiatric disorders) were excluded from the study. Also, pregnant ladies and those with chronic drug intake that may alter thyroid hormone level as lithium carbonate and amoidarone were excluded.

Methods

Blood samples were collected. An enzyme-linked immunosorbent assay was performed to detect the basal serum concentrations of TSH, FT3, and FT4. This assay was processed according to the instructions and regulations of the used kits. Overt hypothyroidism was defined as elevated TSH (> 10 mU/L) with low T4 (T4 < 4.5 μg/dl), whereas subclinical hypothyroidism was defined as elevated TSH (TSH: > 4.5 mU/L) with normal T4 (normal T4: 4.5-13 μg/dl) [12].

Thyroid ultrasound

All patients were examined in supine position with hyperextended neck, using a high frequency linear-array transducer 7-15 MHz (ultrasound machine; GE brand, Logiq. P5 pro model, GE health care manufacture, France). Scanning was done both in longitudinal and transverse planes. Real time imaging of thyroid lesions was performed using both grayscale and color Doppler techniques. Thyroid ultrasound examinations showed normal thyroid gland shape, size, and echo-pattern or abnormal thyroid ultrasound (diffuse increase size of both thyroid lobes with diffuse heterogeneous echo-pattern, diffuse increase size of both thyroid lobes with multiple nodules, or diffuse increase size of both thyroid lobes with normal echo-pattern).

For all the participants, written informed consent was obtained after the study procedures had been explained. The study protocol and the consent form were reviewed and accepted by the Research Ethic Committee (REC) for Human Subject Research at Faculty of Medicine, Helwan University, Cairo, Egypt (serial: 13-2019).

Statistical analysis

Data were entered and analyzed using the IBM-SPSS software (IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp.). Qualitative data were expressed as frequency and percentage. Chi-square test or Fisher’s exact test according to sample size of cells (expected counts) was used for comparing qualitative data. Chi-square test was used if sample size was ≥ 5 units per cell while Fisher’s exact test was used if sample size was < 5 units in ≥ one cell. Quantitative data were initially tested for normality using Shapiro-Wilk’s test with data being normally distributed if p > 0.050. Presence of significant outliers (extreme values) was tested for by inspecting boxplots. Quantitative data were expressed as mean ± standard deviation (SD) if normally distributed or median and interquartile range (IQR) if not. To compare quantitative data for two groups, independent-samples t test was used for normally distributed data in both groups with no significant outliers otherwise the alternative non-parametric test (Mann-Whitney U test) was used. To compare quantitative data for >two groups, one-way ANOVA test was used for normally distributed data in all groups with no significant outliers otherwise the alternative non-parametric test (Kruskal-Wallis H test) was used. Binary logistic regression was used to predict the likelihood of occurrence of hypothyroidism. For any of the used tests, results were considered as statistically significant if p value ≤ 0.050. Appropriate charts were used to graphically present the results whenever needed [13].

Results

Our study included 212 patients (118 had tension type headache “TTH” and 94 had migraine headache) and 100 control subjects. There were no statistically significant differences between patients and control as regards age and sex distribution (p = 0.491 and 0.449 respectively) Table 1.

Table 1 Age and sex distribution between cases and control
Full size table

Subclinical and overt hypothyroidism were significantly higher in our patients more than control (p = 0.001). Moreover, our patients showed significantly more abnormal gland morphology than healthy control (p = 0.027) Table 2.

Table 2 Thyroid function and ultrasound between cases and control
Full size table

Binary logistic regression (BLR) analysis was run to assess the influence of having migraine or TTH versus no headache on the likelihood that participants will exhibit hypothyroidism (subclinical or overt). The model was statistically significant (p = 0.001). The model correctly classifies 76.8% of cases. Patients with migraine or TTH had 3.73 times higher odds to exhibit hypothyroidism (BLR = 1.316, 95% CI = 1.82-7.64, p = 0.001). Logistic regression analysis was also run to assess the influence of having chronic tension headache vs other types (frequent and infrequent) on the likelihood that participants will exhibit hypothyroidism (subclinical or overt). The model was statistically significant (p = 0.002). the model correctly classifies 71.2% of cases. Patients with chronic subtype had 3.57 times higher odds to exhibit hypothyroidism (BLR = 1.272, 95% CI = 1.55-8.22, p = 0.003) (Table 3).

Table 3 Predictors of the likelihood of occurrence of hypothyroidism
Full size table

Migraine patients were significantly younger than tension type headache patients (p = 0.001). There were no significant differences between both migraine and TTH as regards gender, thyroid function, or even abnormal thyroid morphology (Table 4).

Table 4 Age, gender, and thyroid profile between tension headache and migraine
Full size table

Using intragroup comparative statistics, hypothyroidism is significantly expressed in chronic TTH more than TTH with infrequent or even frequent attacks (p = 0.009). Moreover, chronic TTH had older age than other TTH subgroups but not statistically significant differences (p = 0.596). Thyroid gland abnormalities were more common in chronic TTH but with insignificant power (p = 0.227) (Table 5).

Table 5 Intragroup analysis between tension headache subtypes
Full size table

Intragroup analytical statistics of migraine patients regarding age of onset, disease duration, gender, and thyroid gland parameters were analyzed in Table 6. There were no statistically significant differences between migraine with aura, migraine without aura, and chronic migraine as regards age, sex, thyroid functions, or thyroid abnormalities on ultrasound (p > 0.05).

Table 6 Intragroup analysis between migraine subtypes
Full size table

Discussion

Tension-type headache and migraine are among the top six most prevalent diseases globally, and represent the third cause of disability worldwide in individuals under the age of 50 [14].

In pathogenesis of migraine attacks, the role of hormonal regulation is proved by the presence of its menstrual-dependent variants. But the data about the role of thyroid hormones in migraine not confirmed with many contradictory studies [15]. Hagen and his colleagues found low headache prevalence among patients with hypothyroidism [16] while others observed high prevalence of chronic migraine in patients with hypothyroidism [17]. Migraine, tension headache, and hypothyroidism are clinical problems that affect patient daily activities and quality of live with established comorbidity that has been known for more than 60 years [18, 19].

Hypothyroidism in our study was more common in females than males (in both migraine and tension headache together) although not statistically significant (p = 0.448). The female preponderance in our study was consistent with Khan and his colleagues which found higher prevalence of both migraine and TTH in patients with hypothyroidism [20]. While other study reported that women with hypothyroidism were protected from headache [16].

We have found in our study of 212 patients (migraine and tension headache) that there was significantly higher proportion with subclinical (23.3%) and overt hypothyroidism (6%), as compared to the control subjects of 9% and 1%. This was in agreement with the results from other studies [21, 22].

Lima Carvalho and his colleagues found in a population of 213 patients with de novo hypothyroidism (133 of them with subclinical hypothyroidism) that new onset headache developed in 34% of the patients, with a predominantly migraine phenotype, while 78% of patients (with both overt and subclinical hypothyroidism) treated with levothyroxine for 12 months demonstrated improvement of headache symptoms [23].

In contrast to our findings, a cross-sectional study of 130 out-patient migraineurs revealed abnormal levels of TSH only in 5% of patients, and also that lower TSH values were associated with more prolonged migraine attacks and with a greater impact on quality of life [24].

Moreover, our patients showed significantly more abnormal gland morphology than healthy control on thyroid gland ultrasound. The subclinical and overt hypothyroidism prevalence in our patients with migraine and tension headache were also higher than that reported in the general population. The prevalence of subclinical hypothyroidism in general population ranges from 4-10% [25] and that of overt hypothyroidism is 1-2% [26], and is in agreement with our control group.

In our study, binary logistic regression analysis showed that patients having migraine and TTH were more prone to develop hypothyroidism when compared with control group (BLR = 1.316, 95% CI = 1.82-7.64, p = 0.001). Also patients with chronic TTH are susceptible to develop hypothyroidism (either subclinical or overt) 3.57 times when compared with patients having frequent or infrequent TTH (BLR = 1.272, 95% CI = 1.55-8.22, p = 0.003).

There are several mechanisms that may explain the association between migraine and hypothyroidism. Changes in the immune system that occur as a result of migraine may predispose to thyroid autoimmunity [27].

In addition, migraineurs demonstrate sympathetic hypo function during interictal periods, which may increase the risk for hypothyroidism [28].

Genetic factors, such as hyperhomocystemia and shared environmental factors, including air pollutants and synthetic compounds [29] could also predispose to both migraine and hypothyroidism. Singh proposed a possible pathophysiological link between migraine and hypothyroidism. He suggested that pain is regulated by reciprocal modulation of brain stem serotonergic and noradrenergic nuclei. The failure of one of the two systems implies a compensatory response of the other. Thus, the decreased adrenergic tone in hypothyroidism could upregulate the serotonergic response which causes headache.

In our study, migraine patients were significantly younger than tension type headache patients (p = 0.001). This is in agreement with Okumura and his colleagues [30]. There were no significant differences between both migraine and TTH as regards gender, thyroid function or even abnormal thyroid morphology. About one-third of our patients showed abnormal thyroid function (29.7%) whether subclinical or overt hypothyroidism and only 10.3% of them had abnormal gland morphology, these findings are consistent with many previous observation [31, 32].

In the study of Ekici and Cebeci, subclinical hypothyroidism was found in only (5.1%) of patients with migraine [33] while Parashar and his colleagues did not find any changes in thyroid hormone levels with migraine or TTH [34], Larner did not reveal migraine headache associated with hypothyroidism [35], and hypothyroidism were associated with lower frequency of occurrence of headaches in all age groups [16].

In our study, the frequency of tension headache was 55.7% and migraine headache 44.3% and this observation is partially agreed with Hagen and his colleagues [36] as they reported that prevalence of TTH was 51.9%, meanwhile for migraine was 17.2%. Moreover, Stovner and his colleagues found 11% of their patients had migraine and 42% had tension-type headache [37].

Intragroup comparative analysis of TTH patients revealed that patients with chronic TTH were significantly older than other subtypes (p = 0.010) and have longer disease duration than episodic TTH (p = 0.001). Moreover, 46.3% of those patients suffered from chronic TTH have overt hypothyroidism versus 20% and 19.1% of those with frequent TTH and infrequent TTH respectively (p = 0.009), this is in agreement with Khan and his colleagues reported that frequency of hypothyroidism was more common in chronic TTH as compared to episodic TTH [38]. More recently, Qu with his colleagues [39] observed in chronic TTH there were lower levels of T3 and T4 and higher level of TSH than controls.

Regarding sub analysis of migraine patients, there were no significant differences between migraine with aura, migraine without aura, or chronic migraine as regards thyroid function or morphology (p = 0.137 and p = 0.468 respectively) and this is consistent with a recent Russian study who reported negative results regarding comorbidities of migraine and hypothyroidism with abnormal levels of TSH in only 5% of their migraine patients. On the other hand, many other studies [40, 41] found that hypothyroidism was statistically significantly higher in chronic migraine when compared with migraine without aura but when compared with migraine with aura it was statistically insignificant.

Conclusion

Hypothyroidism is a common comorbidity with migraine and TTH. Patients having migraine and TTH more prone to develop hypothyroidism when compared with control group. Also patients with chronic TTH are susceptible to develop hypothyroidism (either subclinical or overt) when compared with patients having frequent or infrequent TTH.

Limitations of the study

We did not investigate the etiopathological relationship between hypothyroidism and other types of headache disorders whether there is a true interactions or just by a chance. We did not address the effect of treatment of thyroid dysfunction on severity and the course of headache. Moreover, the limited number of patients and control (small sample size) beside we did not recruit other cases of primary headache disorder may be a limitation of our study.

Recommendations

Study the response of patients suffering from migraine or tension headache using conventional measures and having hypothyroidism when controlling thyroid function. Sufficient number of patients with migraine, tension headache and control subjects for detection the accurate relationship. Study the relationship between other types of primary headache disorders and hypothyroidism. Moreover, study if there is relationship between primary headache disorders and thyroid dysfunction whether hypo or hyperthyroidism.

Availability of data and materials

The data supporting the results of this article are included within the article.

Abbreviations

FET:

Fisher’s exact test

ICHD-III:

International Classification of Headache Disorder version III

IQR:

Interquartile range

K.W:

Kruskal-Wallis

REC:

Research Ethical Committee

SD:

Standard deviation

TTH:

Tension type headache

TSH:

Thyroid stimulating hormone

T4:

Thyroxine

T3:

Triiodothyronine

Us:

Ultrasound

References

  1. Vos T, Abajobir AA, Abate KH, Kaja A, Abbas M, Agrawa A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1211–59.

    Article  Google Scholar 

  2. Steiner TJ, Stovner LJ, Vos T. GBD: migraine is the third cause of disability in under 50s. J Headache Pain. 2016;17:104.

    Article  Google Scholar 

  3. Headache Classification Committee of the International Headache S. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.

    Article  Google Scholar 

  4. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211.

  5. Spanou I, Bougea A, Liakakis G, Rizonaki K, Anagnostou E, Duntas L, et al. Relationship of migraine and tension-type headache with hypothyroidism: a literature review. Headache. 2019;59(8):1174–86.

    Article  Google Scholar 

  6. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23:455–68.

    Article  CAS  Google Scholar 

  7. Aloisi AM, Vodo S, Buonocore M. Pain and thyroid hormones. Neurol Sci. 2013;34:1501–8.

    Article  Google Scholar 

  8. Lisotto C, Mainardi F, Maggioni F, Zanchin G. The comorbidity between migraine and hypothyroidism. J Headache Pain. 2013;1:138.

    Article  Google Scholar 

  9. Rainero I, Govone F, Gai A, Vacca A, Rubino E. Is migraine primarily a metabolon-endocrine disorder? Curr Pain Headache Rep. 2018;22:36.

    Article  Google Scholar 

  10. Schwedt TJ. Chronic migraine. BMJ. 2014;348:1416.

    Article  Google Scholar 

  11. Bendtsen L, Evers S, Linde M, et al. EFNS guideline on the treatment of tension-type headache – report of an EFNS task force. Eur J Neurol. 2010;17:1318.

    Article  CAS  Google Scholar 

  12. Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009;84(1):65–71.

    Article  Google Scholar 

  13. Heyen Petra. The principle of biomedical statistics: Masur H, Papke K, Althoff S., andOberwittler C.: Scales and scores in neurology; quantification of neurologicaldeficit in research and practice. Thieme Stuttgart New York 2004; 3: 13-51.

  14. Leonardi M, Raggi A. Burden of migraine: international perspectives. Neurol Sci. 2013;34(Suppl 1):S117–8.

    Article  Google Scholar 

  15. Starikova NL, Baidina TV, Kalashnikova TP. Thyrotropin levels and severity of symptoms in migraine patients of tertiary headache center. International Headache Society. 2018:1–5.

  16. Hagen K, Bjero T, Zwart JA, Vatten L, Stovner LJ, Bovim G. Low headache prevalence amongst women with high TSH values. Eur J Neurol. 2001;8:693–9.

    Article  CAS  Google Scholar 

  17. Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB. Chronic daily headache: identification of factors associated with induction and transformation. Headache. 2002;42:575–81.

    Article  Google Scholar 

  18. Younger DS. Epidemiology of migraine. Neurol Clin. 2016;34(4):849–61.

    Article  Google Scholar 

  19. Fallah R, Mirouliaei M, Bashardoost N, Partovee M. Frequency of subclinical hypothyroidism in 5-15 years old children with migraine headache. J Pediatr Endocrinol Metab. 2012;25:859–62.

    Article  Google Scholar 

  20. Khan HB, Shah PA, Bhat MH, Imran A. Association of hypothyroidism in patients with migraine and tension type headache disorders in Kashmir. North India. Neurology Asia. 2015;20(3):257–26.

    Google Scholar 

  21. Olesen J. The International Classification of Headache Disorders, 2nd Edition. Cephalgia. 2006;26(12):1409–10.

    Article  CAS  Google Scholar 

  22. Singh SK. Prevalence of migraine in hypothyroidism. J Assoc of Phys of India. 2002;50:1455–6.

    CAS  Google Scholar 

  23. Lima Carvalho MF, de Medeiros JS, Valenca MM. Headache in recent onset hypothyroidism: prevalence, characteristics and outcome after treatment with levothyroxine. Cephalalgia. 2017;37:938–46.

    Article  Google Scholar 

  24. Starikova NL, Baidina TV, Kalashnikova TP. Thyrotropin levels and severity of symptoms in migraine patients of tertiary headache center. Cephalalgia. 2019;39:148–52.

    Article  Google Scholar 

  25. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Peter A. Singer PA, et al. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Endocrine Practice 2005; 10:1:581-585.

  26. Tietjen GE, Herial NA, Hardgrove J, Utley C, White L. Migraine comorbidity constellations. Headache. 2007;47(6):857–65.

    Article  Google Scholar 

  27. Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology. 2005;64:S9–S15.

    Article  Google Scholar 

  28. Silva JE, Bianco SD. Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid. 2008;18:157–65.

    Article  CAS  Google Scholar 

  29. Szyszkowicz M, Kaplan GG, Grafstein E, Rowe BH. Emergency department visits for migraine and headache: a multi-city study. Int J Occup Med Environ Health. 2009;22:235–42.

    PubMed  Google Scholar 

  30. Robles-Osorio ML, Zacarias-Rangel V, GarcıaSolıs P, Hernandez-Montiel HL, Solıs JC, et al. Prevalence of thyroid function test abnormalities and anti-thyroid antibodies an open population in central Mexico. Rev Investig Clin. 2014;66:113–20.

    Google Scholar 

  31. Amy JR. Tests of thyroid function in chronic headache patients. Headache. 1987;27:351–3.

    Article  CAS  Google Scholar 

  32. Ekici B, Cebeci AN. The debate on the link between subclinical hypothyroidism and childhood migraine: is initial endocrinological evaluation necessary for children with migraine? Acta Neurol Belg. 2015;115:123–7.

    Article  Google Scholar 

  33. Parashar R, Bhalla P, Rai NK, Pakhare A, Babba R. Migraine: is it related to hormonal disturbances or stress? Int J Womens Health. 2014;6:921–5.

    Article  CAS  Google Scholar 

  34. Larner AJ. Thyroid dysfunction and headache. J Headache Pain. 2006;7:51–2.

    Article  Google Scholar 

  35. Okumura T, Tanno S, Ohhira M, Tanno S, Nozu T. Characteristics in patients with headache in an outpatient clinic in Japan. Asia Pacific Family Medicine. 2010;9:10.

    Article  Google Scholar 

  36. Rubino E, Rainero I, Garino F, Vicentini C, Govone F, Vacca A, et al. Subclinical hypothyroidism is associated with migraine: a case-control study. Cephalalgia. 2019;39:15–20.

    Article  Google Scholar 

  37. Stovner LJ, Al Jumah M, Birbeck GL, Gururaj G, Jensen R, Katsarava Z, et al. The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against Headache. J Headache Pain. 2014;27:15–5.

  38. Hagen K, Zwart JA, Aamodt AH, Nilsen KB, Bråthen G, Helde G. etal. A face-to-face interview of participants in HUNT 3: the impact of the screening question on headache prevalence. J Headache Pain. 2008;9:289–94.

    Article  Google Scholar 

  39. Qu P, Yu JX, Xia L, Chen GH. Cognitive performance and the alteration of neuroendocrine hormones in chronic tension-type headache. Pain Pract. 2018;18:8–17.

    Article  Google Scholar 

  40. Le H, Tfelt-Hansen P, Russell MB, Skytthe A, Kyvik KO, Olesen J. Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia. 2011;31:43–64.

    Article  Google Scholar 

  41. Sheftell ME, Rapoport FD, Alan M, Tepper AM, Stewart J, Richard B. Chronic daily headache: identification of factors associated with induction and transformation. Headache. 2002;42(7):575–81.

    Article  Google Scholar 

Download references

Acknowledgements

The authors are grateful to all patients and control subjects for their willingness to participate in this study.

Funding

There is no source of funding for the research.

Author information

Authors and Affiliations

  1. Faculty of Medicine, Badr University Hospital, Helwan University, Cairo, Egypt

    Ali A. Abou Elmaaty

  2. Faculty of Medicine, Mansoura University, Mansoura, Egypt

    Mohamed E. Flifel & Tamer Belal

  3. Faculty of Medicine, Port Said University, Port Said, Egypt

    Carmen A. Zarad

Authors
  1. Ali A. Abou Elmaaty
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed E. Flifel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tamer Belal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carmen A. Zarad
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AAM, MEF, TB, and CAZ carried out the work. AAM designed the study and collected the patients and gathered the clinical data. MEF did the statistical analysis. TB was responsible for collecting the scientific data and writing the initial draft of the manuscript. CAZ collected and reported the radiological data of all patients US. The authors read and approved the final version to be published.

Corresponding author

Correspondence to Ali A. Abou Elmaaty.

Ethics declarations

Ethics approval and consent to participate

The authors obtained permission to conduct this study and was approved by Research Ethic Committee (REC) for Human Subject Research at Faculty of Medicine, Helwan University, Cairo, Egypt (serial: 13-2019) and all participants gave written informed consent. The procedures followed were in accordance with our protocol. An informed consent was obtained from all the patients studied.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abou Elmaaty, A.A., Flifel, M.E., Belal, T. et al. Migraine and tension headache comorbidity with hypothyroidism in Egypt. Egypt J Neurol Psychiatry Neurosurg 56, 78 (2020). https://doi.org/10.1186/s41983-020-00208-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s41983-020-00208-w

Keywords